Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated with Anifrolumab in the Early Access Programs. - ERYTHRO

Study identifier:D3461R00058

ClinicalTrials.gov identifier:NCT06046534

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

ERYTHRO Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated with Anifrolumab in the Early Access Programs.

Medical condition

Systemic Lupus Erythematosus

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

37

Study type

Observational

Age

18 Years - 130 Years

Date

Study Start Date: 27 Oct 2023
Primary Completion Date: 10 Jun 2024
Study Completion Date: 10 Jun 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jun 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

CernerEnviza / Oracle

Inclusion and exclusion criteria